Nrx pharmaceuticals to report year-end 2021 results on march 31, 2022

--company to host conference call march 31, 2022, at 8:30am et--- radnor, pa. , march 28, 2022 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals"), a clinical-stage, biopharmaceutical company today announced that management will report year end 2021 financial results prior to the market open on march 31, 2022.

NRXP Ratings Summary

NRXP Quant Ranking